Filter
259
Text search:
drug
manufacturing
Featured
Recommendations
24
New Publications
54
Language
Document type
No document type
107
Studies & Reports
59
Guidelines
50
Strategic & Response Plan
17
Manuals
13
Fact sheets
6
Situation Updates
3
Resource Platforms
2
Training Material
1
Brochures
1
Countries / Regions
Ghana
14
Global
13
Kenya
12
India
8
Ethiopia
7
Uganda
6
Zimbabwe
6
South Africa
6
Zambia
5
Tanzania
5
Botswana
5
Western and Central Europe
5
Nigeria
4
Malawi
4
South–East Asia Region
4
Africa
4
Philippines
3
Nepal
3
Eastern Europe
3
Sierra Leone
2
Senegal
2
Rwanda
2
Sudan
2
Latin America and the Carribbean
2
Congo, Democratic Republic of
1
Cameroon
1
Pakistan
1
Syria
1
Cambodia
1
Indonesia
1
Bangladesh
1
Mozambique
1
Ukraine
1
Lesotho
1
Asia
1
Tajikistan
1
Russia
1
Moldova
1
Uzbekistan
1
Vietnam
1
Turkmenistan
1
Maldives
1
Authors & Publishers
Publication Years
Category
Countries
100
Clinical Guidelines
17
Pharmacy & Technologies
14
Key Resources
10
Public Health
8
Women & Child Health
3
Capacity Building
2
Toolboxes
AMR
31
COVID-19
30
Pharmacy
28
HIV
18
TB
18
Mental Health
12
Planetary Health
10
Malaria
5
NTDs
4
NCDs
4
Ebola & Marburg
3
Conflict
3
Rapid Response
3
Specific Hazards
3
Global Health Education
3
Caregiver
3
Health Financing Toolbox
3
Natural Hazards
2
2.0 Rapid Response
2
Disability
1
Cholera
1
Polio
1
Refugee
1
Drug Advisory Board
The manufacturing process is one of the key steps where quality control is required to ensure quality of medicinal products, including herbal medicines. Good manufacturing practices (GMP) is one of
...
Minimizing risk of developing antibiotic resistance and aquatic ecotoxicity in the environment resulting from the manufacturing of human antibiotic.
The Standard, facilitated by BSI Standards Limited (BSI), provides clear guidance to manufacturer
...
Irresponsible pharmaceutical companies fuel the proliferation of superbugs through supply chain pollution, the European Public Health Alliance (EPHA) reports. The advocacy group uncovered lapses such as dirty production and inadequate waste disposal in the production of antimicrobials in China and I
...
Report: A survey conducted among the 27 high MDR-TB burden countries.
March – July 2015
Stop TB Partnership in collaboration with Medecins Sans Frontieres (MSF).
Accessed November 2017.
STATUTORY INSTRUMENTS | SUPPLEMENT No. 8 28th March, 2014 | STATUTORY INSTRUMENTS SUPPLEMENT | to The Uganda Gazette No. 18 Volume CVII dated 28th March, 2014 | Printed by UPPC, Entebbe, by Order of the Government. | STATUTORY INSTRUMENTS | 2014 No. 29.
Constituting the fourth part of the World Drug Report 2022, this booklet focuses on the market dynamics of various stimulants – cocaine, amphetamines and “ecstasy” – and of NPS.
The first chapter contains an analysis of the global market fo
...
The Trends and Developments report presents a top-level overview of the drug phenomenon in Europe, covering drug supply, use and public health problems as well as
...
Pharmaceutical News
Evaluation of Saccharide Content of the WHO 2nd International Standard for Haemophilus Influenzae Polysaccharide Polyribosyl Ribitol Phosphate (PRP) by HPAECPAD Analysis Following Acid Hydrolysis
Consultation Documents
Lamivudine and tenofovir disoproxil fumarate tablets (lami
...
Strategic Overview
Revised Edition
Communication to Healthcare Professionals Mar-2020
This guideline is intended to assist healthcare professionals in the participation of very important process of continuous surveillance of safety and efficacy of the health products which are used in their clinical practice. Continuous evaluation o
...
Table of contents:
- Preface
- Introductory note and acknowledgements
- Commentary
- Chapter 1: Drug supply and the market
- Chapter 2: Drug use prevalence and trends
- Chapter 3:
...
The World Drug Report 2022 is aimed not only at fostering greater international cooperation to counter the impact of the world drug problem on health, governance and security, but also, with its spe
...
The African Centers for Disease Control and Prevention and the African Union together have called for a New Public Health Order which will safeguard the health and economic security of the continent as it strives to meet the aspirations of the Agenda 2063. A key pillar of this mandate seeks to expan
...
Despite high regional demand for vaccines valued at over US$ 1 billion annually, Africa’s vaccine industry provides only 0.1% of global supply. Vaccine inequity and hoarding at the start of the pandemic, which resulted in delays in obtaining COVID-19 doses, stimulated new resolve to address future
...
